Written question asked by Naomi Long (Alliance) on Friday, 12 December 2014, in the House of Commons. It was due for an answer on Tuesday, 16 December 2014. It was answered by George Freeman (Conservative) on Wednesday, 17 December 2014 on behalf of the Department of Health.
Drugs: Licensing
- Question
-
To ask the Secretary of State for Health, how many breast cancer clinicians he spoke to directly when developing his policy on the Off-patent Drugs Bill.
- Answer
-
In developing our response to the Bill, we have taken advice from a number of cancer clinicians including breast cancer specialists and from officials at the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency, and taken account of views expressed by other stakeholder organisations.
Secondary information
- Type
- Written question
- Reference
- 218546
- Session
- 2014-15
- Grouped for answer
- Yes
- Subjects
- Breast cancer Licensing Drugs
- Legislation
- Off-patent Drugs Bill 2014-15
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2015-05-22 08:22:40 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/218546
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/218546
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2014-15/218546